Skip to content
Home page - Centenary Institute Centenary Institute

Primary menu

  • Research
        • Research

          The latest medical research into our most complex health challenges across biomedical AI, cancer, cardiovascular diseases, inflammation, immunity, age-related, rare and infectious diseases.

          Learn more

        • Biomedical AI
        • Cancer Innovations
        • Cardiovascular Research
        • Healthy Ageing
        • Infection & Immunity
        • Inflammation
        • Rare Diseases & Gene Therapy
        • Laboratories
        • Diseases
        • Expertises
        • Breakthroughs
        • Technologies
          • Clinical Translation
  • Support us
        • Support us

          By supporting the Centenary Institute you can help improve human health through excellence in medical research

          Learn more

        • Workplace giving
        • Host or join a fundraiser
        • Gift in your Will
        • Donate in Memory
        • Community and research
  • Careers & students
        • Careers & Students

          Postdoctoral and postgraduate students can work alongside world-leading medical researchers within state-of-the-art research facilities.

        • Career Opportunities
        • Student Opportunities
  • Health hub
        • Health hub

          A range of practical information to assist in the possible preventions to disease through evidence-based research on how the body works.

          Learn more

        • Inflammation
        • The Good Gut Anti-Inflammatory Diet
          • Healthy Recipes
        • Ageing
        • Exercise Snack Program
  • News & events
        • News & Events

          Explore the latest research breakthroughs and ways you can take part in our series of digital and in-person events

        • News
        • Events
        • Media Hub
          • Statements
        • Real stories
  • About us
        • About us

          We are world-leading independent medical research institute that drives collaboration to accelerate and translate solutions to our most complex health challenges

          Learn more

        • Governance
        • Corporate information
        • Annual reports
        • Our researchers
          • Animals in research
        • Contact
  • Donate
    Centenary Institute > News > Award to fund innovative CAR-T cell therapy research

Award to fund innovative CAR-T cell therapy research

Date time 4 August, 2023
News Type News type Media release
Dr Mehdi Sharifi Tabar, a researcher from the Gene and Stem Cell Therapy Program at the Centenary Institute, has been announced as the recipient of the 2023 Kenyon Foundation Inflammation Award.

The $20,000 award will support Dr Tabar’s research into enhancing the effectiveness of CAR-T cell therapy, an innovative cancer treatment that involves modifying a patient’s own immune cells into CAR-T cells to target and destroy cancer.

While CAR-T cell therapy has shown remarkable success in treating blood cancers, its ability in combating solid tumours is limited.

“We have successfully treated towards one hundred patients with blood cancers using CAR-T cells at the Royal Prince Alfred Hospital but they still haven’t been shown to work for more common cancers,” observed Professor John Rasko AO, who is Head of the Gene and Stem Cell Therapy Program.

One of the major challenges faced by CAR-T cell therapy is CAR-T cell exhaustion, a phenomenon in which the modified immune cells lose their cancer-fighting ability over time due to prolonged exposure to tumour cells.

Dr Tabar’s research will concentrate on a specific gene that regulates the production of signalling molecules (inflammatory cytokines), which can lead to CAR-T cell exhaustion. By modifying this gene, the goal is to decrease the rate of CAR-T cell exhaustion and improve the tumour-killing potential of CAR-T cells.

“CAR-T cells produce signalling molecules in response to cancer cells. They help to activate other immune cells and enhance the anti-cancer immune response,” explained Dr Tabar.

“However, the excessive release of these signalling molecules can cause CAR-T cells to over-activate leading to CAR-T cell exhaustion, which can limit the efficacy of CAR-T cell therapy. By genetically ‘turning down’ the production of these signalling molecules, we may be able to reduce exhaustion levels and ultimately improve cancer treatment outcomes for patients.”

Pancreatic cancer models will be used by Dr Tabar to test the approach with the insights gained likely to improve the understanding and effectiveness of CAR-T cell therapy in a broader cancer context.

“I’m extremely grateful for the Kenyon Foundation’s support,” said Dr Tabar.

“The funding will allow me to undertake research that has the potential to overcome the challenge of CAR-T cell exhaustion and unlock the full potential of this exciting cancer treatment.”

Trustee of the Kenyon Foundation, David Kenyon, expressed his enthusiasm for the innovative research.

“The Foundation is delighted to continue its support of, and investment in, the careers of outstanding researchers such as Dr Tabar, to improve our understanding of human health and ultimately provide better outcomes for the community,” said Mr Kenyon.

“Dr. Tabar’s important research has the potential to advance the knowledge and application of CAR-T cell therapy and to improve the lives of those affected by cancer, a truly devastating disease.”

Media enquires

For all media and interview enquiries, please contact Tony Crawshaw

Phone number Phone Number +61 402 770 403

Email Email t.crawshaw@centenary.org.au

Media Release

Award to fund innovative CAR-T cell therapy research

Download

Recent Stories

  • New platform to evolve proteins for better therapies

    Researchers from the Centenary Institute, in collaboration with the University of Sydney, have developed a powerful new tool to evolve proteins directly within mammalian cells, offering a more effective way to design medical treatments tailored to the human body.
    News Type: Media release
    Date 08 May 2025
  • Turning off protein may help prevent liver cancer

    New research from the Centenary Institute has found that switching off a specific protein in liver cells may help prevent the early development of liver cancer.
    News Type: Media release
    Date 16 Apr 2025
  • Event shines spotlight on genetic heart disease in young people

    The Centenary Institute has hosted a community event, titled ‘A Needle in a Haystack: Unlocking the Secrets of Genetic Heart Conditions’. The event aimed to advance understanding of inherited heart disease and sudden cardiac death in young people.
    News Type: Community
    Date 10 Apr 2025
  • Finding answers for sudden cardiac death in young people

    Each week in Australia, up to three young people die suddenly and unexpectedly from sudden cardiac death, often due to an undiagnosed genetic heart condition. These conditions typically go unnoticed until tragedy strikes, leaving families devastated and searching for answers.
    News Type: Media release
    Date 02 Apr 2025

Subscribe to receive news on
research updates and free events

Newsletter

The Centenary Institute is a world-leading independent Medical Research Institute.

We acknowledge the Gadigal of the Eora Nation, the traditional custodians of the Country on which the Centenary Institute stands.

About

  • About
  • Governance
  • Corporate information

Research

  • Our researchers
  • News
  • Media hub

Careers & studies

  • Career opportunities
  • Life at Centenary

Links

  • Contact
  • Privacy statement

Contact us

Building 93, Royal Prince Alfred Hospital
Missenden Rd
Camperdown NSW 2050 Australia
Telephone +61 2 9565 6100
Fax +61 2 9565 6101

Contact Privacy

Centenary Institute ABN 22 654 201 090 (DGR 1) • Centenary Institute Medical Research Foundation ABN 85 778 244 012 (DGR 2)
© 2017 Centenary Institute of Cancer Medicine and Cell Biology.

  • Linkedin
  • Facebook
  • Twitter
  • Youtube
  • Instagram